期刊文献+

不同载体对重组人成骨蛋白-1骨诱导活性的影响(英文) 被引量:1

Effects of different carriers on bone inducing activity of recombinant human osteogenic protein-1
下载PDF
导出
摘要 背景:重组人成骨蛋白-1(rhOP-1)的载体目前仅限于胶原,不同载体对其骨诱导活性的影响还未被证实。目的:通过不同材料作为rhOP-1载体的异位骨诱导活性的比较研究,筛选一种较为理想的载体材料。设计:完全随机、自身和相互对照研究。地点和对象:实验在本中心动物实验室完成,实验对象为96只雄性昆明种小鼠。干预:将rhOP-1分别与无活性脱钙骨基质(DBM)、羟基磷灰石(HA)、3种α-聚酯类(PLA,PLA-PEG,PLGA)复合,植入小鼠股部内侧肌间隙,3周后取材,比较5种载体对rhOP-1骨诱导活性的影响。主要观察指标:通过组织学检查、碱性磷酸酶(ALP)及钙含量的测定比较新骨的成熟度和成骨率。结果:rhOP-1/DBM(A)组、单独植入rhOP-1(F)组和真核表达OP-1注入(对照Ⅵ)组均有骨组织生成。A组可见大量骨小梁、骨髓腔和板层骨,血管和骨髓丰富;F组出现编织骨;对照组Ⅵ见成熟的致密骨组织;其余4组复合组可见间充质细胞增生,未见骨组织;载体部分吸收。ALP水平和Ca含量,各复合组均高于对照组,A组高于其他复合组(F=6.250,P<0.05);F组与对照Ⅵ差异无显著性意义(F=2.704,P>0.05);除rhOP-1/DBM组以外,其他各复合组与F组之间差异均无显著性意义(F=0.590,P>0.05)。结论:DBM为rhOP-1的良好载体;DBM/rhOP-1对临床上促进骨缺损的修复是十分有利的? BACKGROUND: The carriers of recombinant human osteogenic protein 1(rhOP 1) are limited to collagen. The effects of different carriers on its bone inducing activity still have not been proved. OBJECTIVE:To find an optimal carrier material for rhOP 1 through a comparative studies of the effects of different materials on the bone inducing activity. DESIGN: A completely randomized, auto control and mutual control study was used. SETTING AND PARTICIPANTS:Ninety six male mice of Kunming species were recruited in this study and the experiment was completed at the Animal Laboratory of our center. INTERVENTION:The materials included inactive decalcified bone matrix(DBM), hydroxyapatite (HA), polylactic acid(PLA), polylactic acid polyethylene glycol copolymers (PLA PEG) and polylactic glycolic acid(PLGA), and they were compounded with rhOP 1 respectively, and were then implanted into the medial intermuscular septum of the thighs of mice for 3 weeks.Then, samples were taken to evaluate the effects of the five materials on bone inducing activity of rhOP 1. MAIN OUTCOME MEASURE: New bone maturity and osteogenic rate were assessed by histological studies, determination of alkaline phosphatase(ALP) level and calcium content of the entopic new bone. RESULTS:Three weeks after implantation, groups of DBM/rhOP 1(A),rhOP 1(F) and Eukaryon expressed OP 1(control VI) all showed new bone formation.Group A was found to have massive bone trabeculae,marrow cavity, and lamellar bones as well as rich blood vessels and bone marrow.Group F showed appearance of woven bones. In Group VI,there appeared compact bone tissues of maturity.In the rest of the groups,there was proliferation of mesenchymal cells,and part of the materials were absorbed, and no bone was found.ALP level and calcium content were significantly higher in every compound group than in control group, and they were higher in Group A than in other experimental groups(F=6.250,P< 0.05).No significant difference was found between group F and control VI(F=2.704,P >0.05).No significant difference was found between Group F and all other compound groups(F=0.590,P >0.05). CONCLUSION:① DBM is an effective carrier for rhOP 1;② DBM /rhOP 1 is useful to accelerate repairs of bone defects in clinic.
出处 《中国临床康复》 CSCD 2004年第5期963-965,T004,共4页 Chinese Journal of Clinical Rehabilitation
基金 国家科技部基金项目(981154506)~~
  • 相关文献

参考文献3

二级参考文献21

  • 1[2]Yang L,Duan XJ.The front problem of seed cell research in bone tissue engineering.Zhonggou Linchuang Kangfu(Chin J Clin Rehabil) 2002;6:532- 3
  • 2[3]Boden SD.Bioactive factors for bone tissue engineering. Clin Orthop 1999;367: 84- 94
  • 3[4]Niyibizi C, Baltzer A, Lattermann C, et al.Potential role for gene therapy in enhancement of fracture healing.Clin Orthop 1998;355:148- 53
  • 4[5]Scaduto AA, Lieberman JR.Gene therapy for osteoinduction.Orthop Clin North Am 1999;30(4):625- 33
  • 5[6]Evans CH, Robbins PD.Possible orthopaedic applications of gene therapy.J Bone Joint Surg Am 1995;77(7):1103- 14
  • 6[7]Shu JC,Zhang CC.Action and principle of gene transfer in racture heal.Xiandai Kangfu(Modern rehabil) 2001;5:62- 3
  • 7[8]Alend TD, Pittman DD, Hankins GR, et al. In vivo endochondral bone formation using a bone morphogenetic protein 2 adeoviral vector.Human Gene Ther 1999;10(13):2245- 53
  • 8[9]Lieberman JR, Daluiski A, Stevenson S, et al.The effect of regional gene therapy with bone morphogenetic protein- 2 producing bone marrow cells on the repair of segmental femoral defects in rats.J Bone Joint Surg Am 1999;81(7):905- 17
  • 9[10]Okubo Y, Bessho K, Fujimura K,et al.Expression of bone morphogenetic protein 2 via adenoviral vecto on C2C12 myolasts induces differentiation into the osteoblast lineage. Biochem Biophys Res Commun 1999;262(3):739- 43
  • 10[11]Gazit D,Turgeman G,Kelley P, et al.Engineered pluripotent mesenchymal cells integrate and differentate in regeneration bone: a novel cell mediated gene therapy.J Gene Med 1999;1(2):121- 33

共引文献32

同被引文献22

  • 1赵甜娜,韩金祥,王世立.成骨蛋白-1的研究及应用进展[J].生物技术通讯,2005,16(4):435-437. 被引量:1
  • 2Tischler M. Platelet rich plasma: the use of autologous growth factors to enhance bone and soft tissue grafts [ J ]. NY State Dent J 2002, 68(3) :22-24.
  • 3Shea CM, Edgar CM, Einhom TA, et al. BMP treatment of C3H10T1/2 mesenchymal stem ceils induces both cbondregenesis and osteogenesis[J]. Cell Biochem,2003,90 (6) : 1112-1127.
  • 4Wan M ,Cao X. BMP signaling in skeletal development [J], Biochem Biophys Res Commun,2005,328(3) :651-657.
  • 5Cook SD,Salkeld SL,Patron LP,et al. Healing course of primate ulna segmental defects treated with osteogenic protein-1 [ J ]. J Invest Surg,2002,15 (2) :69-79.
  • 6Den boer FC, Bramer JA, Blokhuis TJ,et al. Effect of recombinant human osteogenic protein-1 on the healing of a freshly closed diaphyseal fracture[ J]. Bone, 2002,31 ( 1 ) : 158-164.
  • 7Cunningham BW, Kanayama M, Parker LM,et al. Osteogenic protein versus autologous interbody arthrodesis in the sheep thoracic spine[J]. Spine,1999,24(6) : 509-518.
  • 8Magin MN, Delling G. Improved lumbar vertebral interbody fusion using rhOP-1: a comparison of autogenous bone graft, bovine hydroxylapatite (Bio-Oss) , and BMP-7 (rhOP-1) in sheep [J]. Spine,2001,26(5) : 469-478.
  • 9Vaccaro AR, Patel T, Fischgrund J ,et al. A 2-year fallow-up pilot study evaluating the safety and efficacy of op-1 putty ( rhbmp-7 ) as an adjunct to iliac crest autograft in posterolateral lumbar fusions [J].Eur Spine J,2005,14(7) :623-629.
  • 10Cho TJ, Gerstwnfeld LC, Einhom TA. Ditterential temporal expression of members of the transformation growth factor beta superfamily during murine healing [ J ]. Bone Miner Res, 2002, 17 ( 3 ) : 513- 520.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部